The increased expression levels of SAA1 and SAA2 in margin areas were significantly associated with a worse overall survival (OS) in ICC patients from validation cohort 2 (P < 0.05 for SAA1 and P < 0.05 for SAA2; Supplementary information, Fig. S10a, b). This evidence concerns the gene SAA1 and intrahepatic cholangiocarcinoma.